Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LY3214996 + Cetuximab +/- Abemaciclib in Metastatic Colorectal Cancer
NCT04616183Phase 2Active, not recruiting
- Sponsor
- University of Texas MD Anderson Cancer Center
- Start
- Dec 2020
- Primary completion
- Dec 2028
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of temuterkib in colorectal cancer (CRC), sponsored by University of Texas MD Anderson Cancer Center. Started Dec 2020; status: active, not recruiting.
02
Drugs
temuterkib
03
Conditions
colorectal cancer (CRC)
Beyond the preview
Go deeper on NCT04616183.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04616183.